- Home
- ACCD vs NGNE Comparison
ACCD vs NGNE Comparison
Compare ACCD & NGNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACCD
- NGNE
- Stock Information
- Founded
- ACCD 2007
- NGNE 2003
- Country
- ACCD United States
- NGNE United States
- Employees
- ACCD N/A
- NGNE N/A
- Industry
- ACCD Business Services
- NGNE Biotechnology: Pharmaceutical Preparations
- Sector
- ACCD Consumer Discretionary
- NGNE Health Care
- Exchange
- ACCD Nasdaq
- NGNE Nasdaq
- Market Cap
- ACCD 281.1M
- NGNE 230.0M
- IPO Year
- ACCD 2020
- NGNE N/A
- Fundamental
- Price
- ACCD $6.93
- NGNE $17.36
- Analyst Decision
- ACCD Hold
- NGNE Strong Buy
- Analyst Count
- ACCD 11
- NGNE 6
- Target Price
- ACCD $6.22
- NGNE $60.80
- AVG Volume (30 Days)
- ACCD 1.7M
- NGNE 277.9K
- Earning Date
- ACCD 01-10-2025
- NGNE 11-18-2024
- Dividend Yield
- ACCD N/A
- NGNE N/A
- EPS Growth
- ACCD N/A
- NGNE N/A
- EPS
- ACCD N/A
- NGNE N/A
- Revenue
- ACCD $446,718,000.00
- NGNE $925,000.00
- Revenue This Year
- ACCD $14.47
- NGNE N/A
- Revenue Next Year
- ACCD $12.51
- NGNE N/A
- P/E Ratio
- ACCD N/A
- NGNE N/A
- Revenue Growth
- ACCD 14.99
- NGNE N/A
- 52 Week Low
- ACCD $3.08
- NGNE $14.42
- 52 Week High
- ACCD $11.16
- NGNE $74.49
- Technical
- Relative Strength Index (RSI)
- ACCD 81.29
- NGNE 44.25
- Support Level
- ACCD $6.86
- NGNE $16.72
- Resistance Level
- ACCD $6.93
- NGNE $19.97
- Average True Range (ATR)
- ACCD 0.04
- NGNE 2.39
- MACD
- ACCD -0.10
- NGNE 0.08
- Stochastic Oscillator
- ACCD 78.95
- NGNE 19.43
About ACCD Accolade Inc.
Accolade Inc offers technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. The company's platform combines open, cloud-based intelligent technology with multimodal support from a team of Accolade Care Advocates and clinicians, including registered nurses, physician medical directors, pharmacists, primary care physicians, and other professionals to provide advocacy, medical opinion, and virtual primary care services.
About NGNE Neurogene Inc.
Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.